like i posted numerous times PROs' backed THE OUTCOME of a
like i posted numerous times PROs' backed THE OUTCOME of a less than stellar entity's ability to wrest CONtroll of JBI (P2O) which clearly has both *evolved* since 2009 and has *value* that pattern was first noticeable by the remarkable *reality* of having an *orchestrated* run on JBII >> TOTALLY BLOCKED just b4 the July 2012 >> AGM one can then observe the sideways PPS movement until the Fall of 2012 when the *reset/compress/reset* efforts ramped up kick in the occasional *planned* raid .. (K filed/depo gate/CC) and the potential to demoralize investors increases with every *round* undertaken except of course for a handful of days in Jan 2013 .. circumstantial evidence nails an entity *selling* JBII at (approx) 77c .. BEFORE >> the sec settlement was *announced* that *orchestration* got to 1.49 b4 being undertaken yet again for 4 years the A co. was touted as the 2nd coming it's being groomed for IPO status .. with very powerful *backers* isn't it telling that every other co. out there isn't labeled a scam after all none of these other co.s are yet public (US based) let alone file with the dolts and yet this can be measured .. where others can't .. understand why UP has to be down and white has to be black ... =============== from yesterday .. edited to *CONform* .. take note of the last line
Quote:
duh is totally appropriate re: disruptive techs and which co. becomes the 800 pound gorilla in this newly emerging sector
for 4 years this board has had the A co. touted as the 2nd coming
re: selling shares .. since true comps can't be done because there
are no apple to apple comps .. one can read K*OR's filings from
their IPO debut .. and notice some rather *revealing* aspects
when comp'd to JBI/JBII (co./stock)
it is also beyond revealing that the ideal shareholder became the co.s CEO
4 years of observing both progress and underlying efforts to thwart
and yet RH just put 3M into JBI .. :)
access to capital is not a dirty word .. nor has it ever been an issue for JBI
folks only *lose* or gain $ >> when they sell .. beyond revealing
the *compression/reset/short cycle* has run unabated for well
over a year+ .. with one exception (a handful of days in Jan
2013 when the sec settlement was announced)
how revealing that a *whale* >> SOLD @ 77c (approx) mere days before
the sec settlement was *announced*
snicker
this corruption endemic in this stock has long since morphed beyond
the PROs' *usual cycle* of P&D of JBII >> that was so circa 2009
hooks are embedded deep .. truly comes as no surprise ..
risk rises the closer P2O moves to *proof of concept*
that too comes as no surprise to this actual shareholder
====
now here's a thought .. re: what mgmt can do when they are *ready*
to annihilate *some*
seat the BoD
file an 8k on 3's ops (audit)
file an 8k on the sale of a proc to X co. @ Y price tag
i've always recognized the risk and *realistic* time frames re: JBI
(check out that MAY 2012 IPO debacle to see how long it took
from incubation to IPO for that *disruptive tech* that has yet
to monetize)
JBII has a SS to be envied at this level .. they aren't measured
in the BILLION + like the aforementioned IPO
it's also beyond revealing that funding has never been an issue
lastly .. who can forget the actual time lost based on *KNOWN* bogus bs
that would be the dolt's crap done by rote (tells me this particular
level of cretinous filth has CONnections) >> shocker i know
the unKNOWN is circumstantial *rumours* >> of gross and egregious
incompetence .. deliberate .. or bought and paid for in advance
so the *outcome* to collect the IP for pennies on the $ would
spell success
i have called this latest *round* since the summer of 2012 ..
when i noted there were 3 outcomes in play for JBI (company)
one of which was for the co. to be taken private by >> er >> whales
who would have (if they could have) debuted P2O as an IPO to
compete with other co.s being groomed in this newly emerging sector
equally clear to me is that one set of PROs' backed the above outcome
and wound up on the wrong side of the *trade* which became even
more clear when RH took over as CEO
multiple levels in play *here* and very little is as it appears
==== 4kids
Plastic2Oil, Inc. (PTOI) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Homecoming Steeped in Nostalgia Orange County’s about to do a serious throwback, folks! Gwen Stefani is set to headline the opening concert at OCVIBE's spanking new concert hall in Anaheim on March 17, 2027. Curious choice for their opener? Hardly. This gal's practically woven into the county’s tapestry—her roots run deep here, enough to make even the casual music...
Continue Reading
A Sweet Collaboration on the Horizon If somebody had told me that cookies could conjure up excitement equivalent to a TV show's new season, I'd have laughed. But here we are—Disney+ and Tiff's Treats are cooking up a storm with blue chocolate chip cookies to celebrate 'Percy Jackson and the Olympians' Season 3 premiere. The Cookie That Packs a Punch Forget ordinary...
Continue Reading
Changing the Game in Credit Analysis When you hear about a company snagging a patent, it's usually a big whoop-de-do; but 2GenPen's latest achievement is making some serious waves. This isn't some 'pat-yourself-on-the-back' sort of news – it's got teeth in the world of finance. These folks just locked down their second U.S. patent, number 12,784,096, and it's all about...
Continue Reading
Tigo Energy Inc.'s Troubles: A Stock Drop and Legal Woes You see, not every day do you wake up to find your investment taking a nose dive by 36.76%. But that’s exactly what happened to Tigo Energy, Inc. (NASDAQ: TYGO) after some shaky announcements. A Rollercoaster for Investors On August 4, 2026, Tigo hit investors with a one-two punch: revised financial outlook and...
Continue Reading
Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...
Continue Reading
York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...
Continue Reading
Why Life Insurance Isn't Just a 'Set It and Forget It' Life insurance isn't some one-time deal you lock in and toss aside. Mike Newell, an insurance pro, highlights how life's shifts—whether in income, dependents, or debt—should drive tweaks to your coverage. As your life story unfolds, so too should the backbone of your financial security. Early Adulthood: Setting...
Continue Reading
A Change at the Helm: Dahlberg Takes Charge Here we go, folks—Sinch, that global powerhouse in customer communications, just got itself a new captain. Jonas Dahlberg is now officially the CEO, after warming the acting CEO seat since June. This ain't your ordinary office shuffle. It's a calculated chess move in the high-stakes tech world. Dahlberg's Path to the Top This...
Continue Reading
LONGWELL's New Fan Brochure Shakes Up Data Center Cooling Alright, let's cut to the chase. LONGWELL, the folks out in Ningbo who live and breathe HVACR and industrial fans, have dropped a new tool that’s going to have OEM engineers raising a glass. This twelve-page axial fan selection guide is a stroke of genius—or at least that's what those of us who've braved the...
Continue Reading
Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...
Continue Reading
" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles